Ellin-Kristina Hillert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ellin-Kristina Hillert has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Arjan Mofers
Department of Medical and Health Sciences, Linköping University, SE-58183, Linköping, Sweden
3 shared publications- Karthik Selvaraju
Department of Medical and Health Sciences, Linköping University, SE-58183, Linköping, Sweden
3 shared publications Alexandra Ahlner
Department of Physics, Chemistry and Biology, Linköping University, SE-58183, Linköping, Sweden
2 shared publicationsBelen Espinosa
Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17177, Stockholm, Sweden
2 shared publications- Elias S. J. Arnér
Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
2 shared publications - Johannes Salomonsson
Department of Physics, Chemistry and Biology, Linköping University, SE-58183, Linköping, Sweden
2 shared publications
Latest Publications
- Open Access
- 20 November 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1
Author Correction: Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- 20 November 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1
Open AccessAuthor Correction: Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- Open Access
- 8 July 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-17
Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
A large number of natural products have been advocated as anticancer agents. Many of these compounds contain functional groups characterized by chemical reactivity. It is not clear whether distinct mechanisms of action can be attributed to such compounds. We used a chemical library screening approach to demonstrate that a substantial fraction (~20%) of cytotoxic synthetic compounds containing Michael acceptor groups inhibit proteasome substrate processing and induce a cellular response characteristic of proteasome inhibition. Biochemical and structural analyses showed binding to and inhibition of proteasome-associated cysteine deubiquitinases, in particular ubiquitin specific peptidase 14 (USP14). The results suggested that compounds bind to a crevice close to the USP14 active site with modest affinity, followed by covalent binding. A subset of compounds was identified where cell death induction was closely associated with proteasome inhibition and that showed significant antineoplastic activity in a zebrafish embryo model. These findings suggest that proteasome inhibition is a relatively common mode of action by cytotoxic compounds containing Michael acceptor groups and help to explain previous reports on the antineoplastic effects of natural products containing such functional groups.
- 8 July 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-17
Open AccessCytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
A large number of natural products have been advocated as anticancer agents. Many of these compounds contain functional groups characterized by chemical reactivity. It is not clear whether distinct mechanisms of action can be attributed to such compounds. We used a chemical library screening approach to demonstrate that a substantial fraction (~20%) of cytotoxic synthetic compounds containing Michael acceptor groups inhibit proteasome substrate processing and induce a cellular response characteristic of proteasome inhibition. Biochemical and structural analyses showed binding to and inhibition of proteasome-associated cysteine deubiquitinases, in particular ubiquitin specific peptidase 14 (USP14). The results suggested that compounds bind to a crevice close to the USP14 active site with modest affinity, followed by covalent binding. A subset of compounds was identified where cell death induction was closely associated with proteasome inhibition and that showed significant antineoplastic activity in a zebrafish embryo model. These findings suggest that proteasome inhibition is a relatively common mode of action by cytotoxic compounds containing Michael acceptor groups and help to explain previous reports on the antineoplastic effects of natural products containing such functional groups.
- 1 April 2019
- Published by Elsevier in Cancer Letters
- Vol. 448, 70-83
Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation
- 1 April 2019
- Published by Elsevier in Cancer Letters
- Vol. 448, 70-83
Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation